Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats.
Transplantation Laboratory, University of Helsinki, Finland.
K
K
Lemström
J
J
Bruning
P
P
Koskinen
C
C
Bruggeman
I
I
Lautenschlager
P
P
Häyry
D000818:Animals; D001013:Aorta, Thoracic / Q000473:pathology / Q000637:transplantation*; D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000150:complications*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control*; D007165:Immunosuppression Therapy / Q000379:methods; D008775:Methylprednisolone / Q000627:therapeutic use*; D009131:Muscle, Smooth, Vascular / Q000473:pathology / Q000637:transplantation; D051381:Rats; D011919:Rats, Inbred Strains; D011920:Rats, Inbred WF; D014184:Transplantation, Homologous / Q000276:immunology*
D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone